Clinical Trial Update: A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the interaction between erythromycin and rivaroxaban in healthy participants and those with renal insufficiency; the trial is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• ERYTHROMYCIN (ERYTHROMYCIN)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Healthy, Renal Insufficiency | Phase 1 | Status: COMPLETED